Effects of Goji vs. Fiber on Macular Degeneration

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age65-95

SponsorUniversity of California, Davis

About this trial

The goal of this project is to conduct a clinical trial in 60 participants ranging from age 65-95 who are at risk for age-related macular degeneration (AMD). The study will evaluate the effects of 14g of goji berry intake or an equivalent amount and type of fiber, five days a week for six months, on visual health, gut microbiome profiles, skin carotenoid measures, and lipoprotein profiles.

Eligibility criteria

Qualifiers

Family history of AMD

Hyperlipidemia or managed diabetes

65 - 95 years of age

Disqualifiers

Dislike of, or allergy to, goji berries or any of the ingredients in the fiber-rich wafers and gummies (wheat, corn, oats, soy, natural orange flavor, xylitol, annatto, pectin, or other food ingredients)

Consumption of > 2 alcoholic drinks per day

Indications of substance or alcohol abuse

Current or planned use of a blood thinner (e.g., Coumadin, Warfarin) at any time during study

Trial design

Treatments tested in this trial

Goji berry
Fiber

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University of California, Davis

Lead sponsor

United States Department of Agriculture (USDA)

Collaborator

Source ClinicalTrials.gov